NIH News Release
NIH Statement on World Tuberculosis Day 2018
Statement of Christine F. Sizemore, Ph.D., Richard Hafner, M.D., and Anthony S. Fauci, M.D.

NIH scientists say advanced vaccines could limit future outbreaks
Novel vaccine technologies are critical to improving the public health response to infectious disease threats.

Immune cells in the retina can spontaneously regenerate
NIH discovery in mice could lead to therapies to reduce vision loss from diseases of the retina.

NIH-supported international team confirms new genetic mutation link to ALS
Breakdowns in KIF5A gene highlight new research path.

Islet transplantation improves quality of life for people with hard-to-control type 1 diabetes
NIH-funded study finds consistent, dramatic improvements among clinical trial participants.

Newly described human antibody prevents malaria in mice
NIAID-led research might help prevent malaria and aid design of next-generation vaccines.

A third of young adults have ridden with an impaired driver, NIH analysis suggests
Marijuana impairment cited most in study of recent high school graduates.

H7N9 influenza vaccine clinical trials begin
Trials for an experimental vaccine for the H7N9 influenza virus are now enrolling volunteers at sites across the United States.

NIH scientists search for the clocks behind aging brain disorders
Study of flies suggests neurodegenerative disorders may speed up aging process.

NIDA’s 2018 Avant-Garde awards highlight immune response and killer cells
NIH’s awards support groundbreaking approaches to HIV prevention and treatment.

Feed Fetched by RSS Dog.